Opaleye Management Inc. Verastem, Inc. Transaction History

Opaleye Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.83 $749,700 - $1.35 Million	-735,000 Reduced 31.61%	1,590,000 $1.84 Million
Q4 2020 Feb 12, 2021	BUY	$1.15 - $2.4 $143,750 - $300,000	125,000 Added 5.68%	2,325,000 $4.76 Million
Q3 2020 Nov 16, 2020	BUY	$1.11 - $1.68 $2.44 Million - $3.7 Million	2,200,000 New	2,200,000 $3.2 Million
Q2 2020 Aug 14, 2020	SELL	$1.69 - $4.2 $2.47 Million - $6.15 Million	-1,463,900 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.26 - $3.38 $1.84 Million - $4.95 Million	1,463,900 New	1,463,900 $3.87 Million

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.12B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.